PRPO Precipio, Inc.

Nasdaq precipiodx.com


$ 20.05 $ -0.53 (-2.59 %)    

Monday, 03-Nov-2025 15:59:50 EST
QQQ $ 622.45 $ 0.00 (0 %)
DIA $ 470.44 $ 0.00 (0 %)
SPY $ 675.67 $ 0.00 (0 %)
TLT $ 89.73 $ 0.00 (0 %)
GLD $ 366.24 $ 0.00 (0 %)
$ 19.97
$ 20.51
$ 19.88 x 50
$ 22.00 x 18
-- - --
$ 3.90 - $ 22.38
4,534
na
32.34M
$ 0.95
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2025 06-30-2025 10-Q
2 05-14-2025 03-31-2025 10-Q
3 03-27-2025 12-31-2024 10-K
4 11-06-2024 09-30-2024 10-Q
5 08-13-2024 06-30-2024 10-Q
6 05-14-2024 03-31-2024 10-Q
7 03-29-2024 12-31-2023 10-K
8 11-13-2023 09-30-2023 10-Q
9 08-11-2023 06-30-2023 10-Q
10 05-12-2023 03-31-2023 10-Q
11 03-30-2023 12-31-2022 10-K
12 11-10-2022 09-30-2022 10-Q
13 08-11-2022 06-30-2022 10-Q
14 05-11-2022 03-31-2022 10-Q
15 03-30-2022 12-31-2021 10-K
16 11-12-2021 09-30-2021 10-Q
17 08-12-2021 06-30-2021 10-Q
18 05-14-2021 03-31-2021 10-Q
19 03-29-2021 12-31-2020 10-K
20 11-13-2020 09-30-2020 10-Q
21 08-13-2020 06-30-2020 10-Q
22 05-14-2020 03-31-2020 10-Q
23 03-27-2020 12-31-2019 10-K
24 11-13-2019 09-30-2019 10-Q
25 08-09-2019 06-30-2019 10-Q
26 05-16-2019 03-31-2019 10-Q
27 04-16-2019 12-31-2018 10-K
28 11-19-2018 09-30-2018 10-Q
29 08-16-2018 06-30-2018 10-Q
30 05-21-2018 03-31-2018 10-Q
31 04-13-2018 12-31-2017 10-K
32 11-20-2017 09-30-2017 10-Q
33 08-22-2017 06-30-2017 10-Q
34 05-18-2017 03-31-2017 10-Q
35 04-13-2017 12-31-2016 10-K
36 11-14-2016 09-30-2016 10-Q
37 08-15-2016 06-30-2016 10-Q
38 05-23-2016 03-31-2016 10-Q
39 04-14-2016 12-31-2015 10-K
40 11-16-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 precipio-terminates-sales-agreement-with-agp

-SEC Filing

 precipio-q2-eps-005-up-from-083-yoy-sales-5654m-up-from-4441m-yoy

Precipio (NASDAQ:PRPO) reported quarterly earnings of $0.05 per share. This is a 106.02 percent increase over losses of $(0.83)...

 precipio-revises-warrant-agreement-with-largest-holder-100k-to-be-exercised-for-cash-200k-through-cashless-conversion

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) has entered into an agreement with its largest warrant holder...

 precipio-q4-adj-ebitda-400k
Precipio Q4 Adj. EBITDA $400K
02/25/2025 14:30:54

 precipio-announces-the-launch-of-a-new-version-of-its-bloodhound-mpn-panel-that-is-now-able-to-distinguish-between-calr-type-1-and-type-2-mutations

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) announces the launch of a new version of its Bloodhound MPN (...

 precipio-reports-03m-cash-generated-by-operations-in-q2-2024

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces that its unaudited non-GAAP Cash Burn/Generated fr...

 precipio-reports-q2-2024-revenue-of-44m-vs-433m-est-expects-pathology-divisions-revenues-will-reach-more-than-15m-per-month-by-year-end

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces that for Q2-2024, its unaudited revenues have grow...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION